Paper41003568
Prevalence and Screening Rates of Hepatitis B and Hepatitis C Infections in Adult Patients with Solitary Organ Tumors.
Abakay S and 6 others. Trop Med Infect Dis, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Prevalence and Screening Rates of Hepatitis B and Hepatitis C Infections in Adult Patients with Solitary Organ Tumors. Papers, record 41003568. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41003568
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Prevalence and Screening Rates of Hepatitis B and Hepatitis C Infections in Adult Patients with Solitary Organ Tumors.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References21
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26231459 | Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. | Lancet | 2015 | https://conductscience.org/library/papers/26231459 | PubMed |
| 2 | 24209764 | Trends in hepatitis B virus screening at the onset of chemotherapy in a large US cancer center. | BMC Cancer | 2013 | https://conductscience.org/library/papers/24209764 | PubMed |
| 3 | 36764320 | Global reporting of progress towards elimination of hepatitis B and hepatitis C. | Lancet Gastroenterol Hepatol | 2023 | https://conductscience.org/library/papers/36764320 | PubMed |
| 4 | 34427860 | APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy. | Hepatol Int | 2021 | https://conductscience.org/library/papers/34427860 | PubMed |
| 5 | 25447850 | American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy. | Gastroenterology | 2015 | https://conductscience.org/library/papers/25447850 | PubMed |
| 6 | 32716741 | Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update. | J Clin Oncol | 2020 | https://conductscience.org/library/papers/32716741 | PubMed |
| 7 | 26595058 | Hepatitis B Virus Reactivation and Prophylaxis During Solid Tumor Chemotherapy: A Systematic Review and Meta-analysis. | Ann Intern Med | 2016 | https://conductscience.org/library/papers/26595058 | PubMed |
| 8 | 26694960 | Prevalence of hepatitis B and C and sensibility of a selective screening questionnaire in patients receiving chemotherapy for solid tumors. | BMC Cancer | 2015 | https://conductscience.org/library/papers/26694960 | PubMed |
| 9 | 19814747 | Screening for hepatitis B in chemotherapy patients: survey of current oncology practices. | Aliment Pharmacol Ther | 2010 | https://conductscience.org/library/papers/19814747 | PubMed |
| 10 | 30249902 | Hepatitis B and C rates are significantly increased in certain solid tumors: A large retrospective study. | J Cancer Res Ther | 2018 | https://conductscience.org/library/papers/30249902 | PubMed |
| 11 | 35576953 | Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review. | Lancet Gastroenterol Hepatol | 2022 | https://conductscience.org/library/papers/35576953 | PubMed |
| 12 | 26566064 | AASLD guidelines for treatment of chronic hepatitis B. | Hepatology | 2016 | https://conductscience.org/library/papers/26566064 | PubMed |
| 13 | 25251832 | HIV and the spectrum of human disease. | J Pathol | 2015 | https://conductscience.org/library/papers/25251832 | PubMed |
| 14 | 26163105 | Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study. | Clin Microbiol Infect | 2015 | https://conductscience.org/library/papers/26163105 | PubMed |
| 15 | 18802412 | Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. | MMWR Recomm Rep | 2008 | https://conductscience.org/library/papers/18802412 | PubMed |
| 16 | 39863345 | AGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation in At-Risk Individuals. | Gastroenterology | 2025 | https://conductscience.org/library/papers/39863345 | PubMed |
| 17 | 33094590 | Hepatitis B Reactivation in HBsAg-negative Anti-HBc-positive patients receiving cytotoxic chemotherapy for solid tumors. | Acta Gastroenterol Belg | 2020 | https://conductscience.org/library/papers/33094590 | PubMed |
| 18 | 32423719 | Human Immunodeficiency Virus in Adolescents: Risk, Prevention, Screening, and Treatment. | Prim Care | 2020 | https://conductscience.org/library/papers/32423719 | PubMed |
| 19 | 32395244 | Reactivation of Hepatitis B Virus: A Review of Clinical Guidelines. | Clin Liver Dis (Hoboken) | 2020 | https://conductscience.org/library/papers/32395244 | PubMed |
| 20 | 23749673 | Immunosuppression and HBV reactivation. | Semin Liver Dis | 2013 | https://conductscience.org/library/papers/23749673 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41003568
GET https://conductscience.org/api/papers/v1/41003568/references?page=2